Andrea Lukes
Carolina Woman's Research and Wellness Center · Carolina Women's Research and Wellness Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrea Lukes as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:55 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06306131 · Phase II Study of Ovulation in Obese WomenInnovaGyn, Inc. · completed · Pregnancy Prevention · principal investigator
- N/ANCT00979342 · Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal SystemHologic, Inc. · completed · Uterine Fibroids, Polyps · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- On Demand Oral Contraception for Obese WomenR43HD107861 · NICHD · INNOVAGYN, INC. · PI DAVID Fitzgerald ARCHER · fiscal years 2023Named on NCT06306131
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:55 UTC. The ranking covers the 200 most relevant of 19 PubMed records, and a shared surname and initials can bring in a namesake. All 19 on PubMed
- Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial.Am J Obstet Gynecol · 1997257 citationsRCR 10.9
- Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.N Engl J Med · 2021163 citationsRCR 14.7
- Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial.Obstet Gynecol · 2010158 citationsRCR 6.5
- Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid.Br J Haematol · 200995 citationsRCR 3.8
- Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study.Fertil Steril · 201765 citationsRCR 3.8
- Safety and immunogenicity of an adjuvanted Escherichia coli adhesin vaccine in healthy women with and without histories of recurrent urinary tract infections: results from a first-in-human phase 1 study.Hum Vaccin Immunother · 202156 citationsRCR 4.1
- Twelve-month outcomes for patients undergoing hysteroscopic morcellation of uterine polyps and myomas in an office or ambulatory surgical center.J Minim Invasive Gynecol · 201537 citationsRCR 2.3
- Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.Obstet Gynecol · 202235 citationsRCR 4.4
- Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial.Obstet Gynecol · 201834 citationsRCR 1.6
- Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding.Curr Med Res Opin · 201030 citationsRCR 1.4